Velaglucerase alfa

VPRIV 400 eenheden, poeder voor oplossing voor infusie

Poeder en oplosmiddel voor oplossing voor infusieNetherlandsAuthorisedAuthorised 26 Aug 2010

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

VprivEuropean UnionAuthorised

VprivCanada · 400 UNIT / VIAL · Powder For Solution · Takeda Canada INCSame brand
Vpriv 400 Unidades Polvo Para Solucion Para PerfusionSpain · 400 U · polvo para solución para perfusión · Takeda Pharmaceuticals International Ag Ireland BranchSame brand
VprivEuropean Union · Takeda Pharmaceuticals International AG Ireland BranchSame brand
VprivCroatiaSame brand
VprivItaly · Polvere per soluzione per infusione endovenosa · Takeda Pharmaceuticals International AG Ireland BranchSame brand
VPRIV 400 unitati

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Velaglucerase alfa

VPRIV 400 eenheden, poeder voor oplossing voor infusie

Poeder en oplosmiddel voor oplossing voor infusieNetherlandsAuthorisedAuthorised 26 Aug 2010

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

VprivEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Romania · 400unitati · pulb. pt. sol. perf. · Shire Pharmaceuticals Ireland Limited

Vpriv 40 U Powder for Solution for InfusionSaudi Arabia · Cangene BioPharma Inc. (CBI)

Vpriv Powder for Solution for Infusion 400 Units/VialSingapore · 10 mg/vial · injection, powder, lyophilized, for solution · Takeda Pharmaceuticals (Asia Pacific) Pte. LTD.

VprivUnited States · 400 UNITS/VIAL · injectable · Shire Human Genetic

VprivUnited States · 200 UNITS/VIAL · powder · Shire Human Genetic

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Velaglucerase alfa
Dosage form: Poeder en oplosmiddel voor oplossing voor infusie
Route: Intraveneus gebruik
Register: Netherlands (CBG-MEB)
Status: Authorised
Status in the register: Ingeschreven
Authorised: 26 Aug 2010
Registration: EU/1/10/646
Marketing authorisation holder: Takeda Pharmaceuticals International AG Ireland Branch
ATC code: A16AB10
Group: Alimentary tract and metabolism
Procedure: EU centralised
Supply: Uitsluitend recept
EMA product number: EMEA/H/C/001249
EU number: EU/1/10/646